TCIM
QTTB icon

TIAA CREF Investment Management’s Q32 Bio QTTB Stock Holding History

TIAA CREF Investment Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$929K Hold
1,862
– – ﹤0.01% 2349
2018
Q4 		$749K Buy
1,862
+1,012
+119% +$383K ﹤0.01% 2400
2018
Q3 		$350K Sell
850
-40
-4% -$13.6K ﹤0.01% 2840
2018
Q2 		$327K Buy
+890
New +$319K ﹤0.01% 2926

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VM
VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TIAA CREF Investment Management's QTTB Position: Q1 2019 in Review

TIAA CREF Investment Management held its Q32 Bio (QTTB) position steady in Q1 2019 at 1,862 shares worth $929K. The position accounts for ﹤0.01% of the portfolio, ranked #2349.

TIAA CREF Investment Management first reported a position in QTTB in Q2 2018 and has held it in 4 quarters since. 66 funds tracked by Wall St. Rank hold QTTB as of Q1 2019.

  • TIAA CREF Investment Management held 1,862 shares of Q32 Bio worth $929K as of Q1 2019.
  • TIAA CREF Investment Management left its Q32 Bio share count unchanged in Q1 2019.
  • Q32 Bio made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2349 holding.
  • TIAA CREF Investment Management first reported a position in Q32 Bio in Q2 2018 and has held it in 4 quarters since.
  • 66 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.